NSCLC (Issue 9) | Special Reports

New Options Possible in Patients With NSCLC and Brain Metastases

November 16, 2015

Clinical Articles

A study published in the Journal of Clinical Oncology found that an EGFR inhibitor, erlotinib, was well tolerated in combination with whole-brain radiation therapy for patients with brain metastases from NSCLC.

ALK-Rearranged NSCLC Brain Metastasis Study Demonstrates Extended Survival

November 16, 2015

Clinical Articles

A paper presenting the results of a retrospective study of patients with ALK-rearranged NSCLC hypothesized that prognosis for patients with NSCLC and brain metastases could be further identified through molecular subtyping.

Dr. Chandra P. Belani on the Importance of Immunotherapies in Treating Lung Cancer

November 14, 2015

Clinical Articles

Chandra P. Belani, MD, deputy director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey College of Medicine, talks about how immunotherapies targeting PD-L1 and PD-1 are showing activity in lung cancer.

Dr. Geoffrey R. Oxnard on When to Change EGFR TKIs

November 14, 2015

Clinical Articles

Geoffrey R. Oxnard, MD, Assistant Professor of Medicine, Harvard Medical School, talks about the treatment options for patients with lung cancer who have become resistant to their first-line treatments.